Oramed Pharmaceuticals (ORMP) Short term Debt (2011 - 2024)
Oramed Pharmaceuticals (ORMP) reported Short term Debt of $32.0 million for Q1 2024, down 37.2% quarter-over-quarter from $51.0 million in Q4 2023.
Oramed Pharmaceuticals (ORMP) Short term Debt (2011 - 2024) Analysis & Trends
Oramed Pharmaceuticals has reported Short term Debt for 11 years, with the latest figure at $32.0 million in Q1 2024.
- For the quarter ending Q1 2024, Short term Debt changed N/A year-over-year to $32.0 million; the trailing twelve-month figure through Mar 2024 stood at $32.0 million (changed N/A YoY), and the FY2023 full-year result was $51.0 million, changed N/A from the prior year.
- Short term Debt for Q1 2024 stood at $32.0 million, down from $51.0 million in the prior quarter.
- The five-year high for Short term Debt was $75.4 million in Q3 2023, with the low at $43000.0 in Q1 2020.
- Historically, Short term Debt has averaged $17.6 million across 4 years, with a median of $90000.0 in 2020.
- Annual changes were most pronounced in 2020 — Short term Debt decreased 21.82% — and 2021, when it surged 102.33%.
- Oramed Pharmaceuticals' Short term Debt stood at $93000.0 in 2020, then sank by 37.63% to $58000.0 in 2021, then surged by 87853.45% to $51.0 million in 2023, then sank by 37.2% to $32.0 million in 2024.
- The last three Short term Debt figures came in at $32.0 million (Q1 2024), $51.0 million (Q4 2023), and $75.4 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 32.03 Mn |
| Dec 31, 2023 | 51.01 Mn |
| Sep 30, 2023 | 75.36 Mn |
| May 31, 2021 | 58,000.00 |
| Feb 28, 2021 | 87,000.00 |
| Nov 30, 2020 | 93,000.00 |
| Aug 31, 2020 | 90,000.00 |
| May 31, 2020 | 50,000.00 |
| Feb 29, 2020 | 43,000.00 |
| Nov 30, 2019 | 96,000.00 |
| Aug 31, 2019 | 64,000.00 |
| May 31, 2019 | 39,000.00 |
| Feb 28, 2019 | 55,000.00 |
| Nov 30, 2018 | 51,000.00 |
| Aug 31, 2018 | 46,000.00 |
| May 31, 2018 | 45,000.00 |
| Feb 28, 2018 | 113,000.00 |
| Nov 30, 2017 | 76,000.00 |
| May 31, 2017 | 61,000.00 |
| Feb 28, 2017 | 60,000.00 |